Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on June 1, 2009. The length of the article is 392 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Infliximab sparks remission in refractory urticaria patients.(DERMATOLOGIC THERAPY)Author: Bruce JancinPublication: Skin & Allergy News (Magazine/Journal)Date: June 1, 2009Publisher: International Medical News GroupVolume: 40 Issue: 6 Page: 29(1)Distributed by Gale, a part of Cengage Learning